| 1 | A Clinicopathologic and Molecular Reappraisal of Myxoinflammatory Fibroblastic Sarcoma—A Controversial and Pathologically Challenging Low‐Grade Sarcoma | 1.7 | 5 | Citations (PDF) |
| 2 | <scp>SSX</scp> and SS18‐SSX Antibodies as Additional Tools for Diagnosing Undifferentiated Neoplasms With the <i>EWSR1::SSX3</i> Fusion | 1.7 | 0 | Citations (PDF) |
| 3 | 54 Ossifying Fibromyxoid Tumors Harbor a Distinct Methylation Signature Regardless of the Fusion Type and Share an Epigenetic Relationship with Myoepithelial Tumors | 1.8 | 0 | Citations (PDF) |
| 4 | Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas | 4.9 | 1 | Citations (PDF) |
| 5 | Orthopaedic Implant-Associated Rhabdomyosarcoma | 1.5 | 1 | Citations (PDF) |
| 6 | Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone—A Single Institution Experience | 1.7 | 1 | Citations (PDF) |
| 7 | Secondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma | 1.7 | 1 | Citations (PDF) |
| 8 | Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions | 1.7 | 13 | Citations (PDF) |
| 9 | Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma | 4.5 | 35 | Citations (PDF) |
| 10 | Complementary value of molecular analysis to expert review in refining classification of uncommon soft tissue tumors | 1.7 | 5 | Citations (PDF) |
| 11 | Kinase fusion positive intra‐osseous spindle cell tumors: A series of eight cases with review of the literature | 1.7 | 6 | Citations (PDF) |
| 12 | When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF::PHF1 fusion | 1.7 | 9 | Citations (PDF) |
| 13 | Translational Aspects of Epithelioid Sarcoma: Current Consensus | 4.5 | 14 | Citations (PDF) |
| 14 | Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype | 3.8 | 13 | Citations (PDF) |
| 15 | Vascular Neoplasms With NFATC1/C2 Gene Alterations | 2.3 | 10 | Citations (PDF) |
| 16 | Chromoplexy Is a Frequent Early Clonal Event in
EWSR1
-Rearranged Round Cell Sarcomas That Can Be Detected Using Clinically Validated Targeted Sequencing Panels | 2.6 | 7 | Citations (PDF) |
| 17 | Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant | 1.7 | 13 | Citations (PDF) |
| 18 | Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma | 4.5 | 31 | Citations (PDF) |
| 19 | Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas | 3.8 | 17 | Citations (PDF) |
| 20 | Spindle cell neoplasms with novel LTK fusion – Expanding the spectrum of kinase fusion‐positive soft tissue tumors | 1.7 | 9 | Citations (PDF) |
| 21 | FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma | 1.7 | 17 | Citations (PDF) |
| 22 | Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma | 1.7 | 10 | Citations (PDF) |
| 23 | Clinicopathologic and molecular correlates to neoadjuvant chemotherapy‐induced pathologic response in breast angiosarcoma | 1.7 | 6 | Citations (PDF) |
| 24 | YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer | 2.8 | 9 | Citations (PDF) |
| 25 | The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations | 4.5 | 8 | Citations (PDF) |
| 26 | Botryoid-type Embryonal Rhabdomyosarcoma | 2.3 | 8 | Citations (PDF) |
| 27 | Molecular Analysis of Renal/Adrenal Angiosarcomas Reveals High Frequency of Recurrent Genetic Alterations | 1.7 | 1 | Citations (PDF) |
| 28 | A potential conundrum in dermatopathology: molecularly confirmed superficial ossifying fibromyxoid tumors with unusual histomorphologic findings and a novel fusion | 1.9 | 6 | Citations (PDF) |
| 29 | FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity | 1.9 | 8 | Citations (PDF) |
| 30 | RREB1::MRTFB fusion‐positive extra‐glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity | 1.7 | 17 | Citations (PDF) |
| 31 | ALK‐rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors | 1.7 | 38 | Citations (PDF) |
| 32 | Histopathologic Grading Is of Prognostic Significance in Primary Angiosarcoma of Breast | 2.3 | 26 | Citations (PDF) |
| 33 | TRAF7-mutated Fibromyxoid Spindle Cell Tumors Are Associated With an Aggressive Clinical Course and Harbor an Undifferentiated Sarcoma Methylation Signature | 2.3 | 12 | Citations (PDF) |
| 34 | Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart | 1.7 | 11 | Citations (PDF) |
| 35 | Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners | 1.7 | 16 | Citations (PDF) |
| 36 | MED15::TFE3
Renal Cell Carcinomas: Report of Two New Cases and Review of the Literature Confirming Nearly Universal Multilocular Cystic Morphology | 0.6 | 19 | Citations (PDF) |
| 37 | Head and Neck Mesenchymal Tumors with Kinase Fusions | 2.3 | 27 | Citations (PDF) |
| 38 | High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations | 3.8 | 10 | Citations (PDF) |
| 39 | Expanding the Molecular Diversity of CIC-Rearranged Sarcomas With Novel and Very Rare Partners | 3.8 | 40 | Citations (PDF) |
| 40 | Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy | 3.3 | 8 | Citations (PDF) |
| 41 | Modeling sarcoma relevant translocations using CRISPR‐Cas9 in human embryonic stem derived mesenchymal precursors | 1.7 | 0 | Citations (PDF) |
| 42 | A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma | 4.5 | 56 | Citations (PDF) |
| 43 | Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in
PDGFRA D842V
-Mutant Gastrointestinal Stromal Tumor | 4.5 | 8 | Citations (PDF) |
| 44 | Ossifying Fibromyxoid Tumor of the Genitourinary Tract | 2.3 | 9 | Citations (PDF) |
| 45 | Adamantinoma-like Ewing Sarcoma (ALES) May Harbor FUS Rearrangements | 2.3 | 14 | Citations (PDF) |
| 46 | Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse | 4.9 | 16 | Citations (PDF) |
| 47 | Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era | 4.5 | 25 | Citations (PDF) |
| 48 | Novel EWSR1::GFI1B gene fusion in angiofibroma of soft tissue | 2.6 | 5 | Citations (PDF) |
| 49 | Low‐grade endometrial stromal sarcoma‐like tumors in male with JAZF1 gene fusions | 1.7 | 9 | Citations (PDF) |
| 50 | Neuregulin 1 (NRG1) fusion‐positive high‐grade spindle cell sarcoma: A distinct group of soft tissue tumors with metastatic potential | 1.7 | 10 | Citations (PDF) |
| 51 | Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations | 1.7 | 25 | Citations (PDF) |
| 52 | A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma | 4.5 | 46 | Citations (PDF) |
| 53 | Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors | 4.5 | 15 | Citations (PDF) |
| 54 | The genetics of vascular tumours: an update | 2.6 | 43 | Citations (PDF) |
| 55 | FGFR2::TACC2 fusion as a novel KIT‐independent mechanism of targeted therapy failure in a multidrug‐resistant gastrointestinal stromal tumor | 1.7 | 12 | Citations (PDF) |
| 56 | Primary Mesenchymal Tumors of the Thyroid Gland: A Modern Retrospective Cohort Including the First Case of TFE3-Translocated Malignant Perivascular Epithelioid Cell Tumor (PEComa) | 1.0 | 16 | Citations (PDF) |
| 57 | Expanding the spectrum of mesenchymal neoplasms with NR1D1‐rearrangement | 1.7 | 12 | Citations (PDF) |
| 58 | Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates | 3.8 | 42 | Citations (PDF) |
| 59 | Teratocarcinosarcoma-Like and Adamantinoma-Like Head and Neck Neoplasms Harboring NAB2::STAT6: Unusual Variants of Solitary Fibrous Tumor or Novel Tumor Entities? | 1.0 | 14 | Citations (PDF) |
| 60 | PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion | 2.3 | 34 | Citations (PDF) |
| 61 | Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center 2022, 10, e004149 | | 51 | Citations (PDF) |
| 62 | GLI1 Gene Alterations in Neoplasms of the Genitourinary and Gynecologic Tract | 2.3 | 39 | Citations (PDF) |
| 63 | Recurrent PTBP1::MAML2 fusions in composite hemangioendothelioma with neuroendocrine differentiation: A report of two cases involving neck lymph nodes | 1.7 | 23 | Citations (PDF) |
| 64 | NUTM1‐fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity | 1.7 | 15 | Citations (PDF) |
| 65 | ZFP64::NCOA3 gene fusion defines a novel subset of spindle cell rhabdomyosarcoma | 1.7 | 14 | Citations (PDF) |
| 66 | Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma | 2.3 | 39 | Citations (PDF) |
| 67 | EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity | 1.7 | 21 | Citations (PDF) |
| 68 | Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls | 1.7 | 23 | Citations (PDF) |
| 69 | Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | 10.8 | 226 | Citations (PDF) |
| 70 | Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma | 10.8 | 55 | Citations (PDF) |
| 71 | Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study | 3.8 | 44 | Citations (PDF) |
| 72 | Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck | 1.7 | 35 | Citations (PDF) |
| 73 | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry | 6.8 | 32 | Citations (PDF) |
| 74 | DICER1-Associated Anaplastic Sarcoma of the Kidney With Coexisting Activating PDGFRA D842V Mutations and Response to Targeted Kinase Inhibitors in One Patient | 1.1 | 9 | Citations (PDF) |
| 75 | An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma | 4.9 | 47 | Citations (PDF) |
| 76 | The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms | 3.8 | 29 | Citations (PDF) |
| 77 | Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study | 1.7 | 43 | Citations (PDF) |
| 78 | Pediatric fibromyxoid soft tissue tumor with PLAG1 fusion: A novel entity? | 1.7 | 30 | Citations (PDF) |
| 79 | Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras | 3.4 | 81 | Citations (PDF) |
| 80 | A Poorly Differentiated Non-keratinizing Sinonasal Squamous Cell Carcinoma with a Novel ETV6-TNFRSF8 Fusion Gene | 1.0 | 8 | Citations (PDF) |
| 81 | Pediatric Mesothelioma With ALK Fusions | 2.3 | 38 | Citations (PDF) |
| 82 | Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts | 3.8 | 58 | Citations (PDF) |
| 83 | Hybrid schwannoma–perineurioma frequently harbors VGLL3 rearrangement | 3.8 | 39 | Citations (PDF) |
| 84 | Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions | 3.8 | 9 | Citations (PDF) |
| 85 | Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab | 1.5 | 5 | Citations (PDF) |
| 86 | Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung | 2.3 | 48 | Citations (PDF) |
| 87 | Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1‐SSX1 fusions | 1.7 | 14 | Citations (PDF) |
| 88 | Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases | 2.6 | 86 | Citations (PDF) |
| 89 | A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma | 2.3 | 38 | Citations (PDF) |
| 90 | Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors | 5.2 | 13 | Citations (PDF) |
| 91 | Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions | 3.8 | 52 | Citations (PDF) |
| 92 | Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors | 1.7 | 25 | Citations (PDF) |
| 93 | Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature | 3.8 | 45 | Citations (PDF) |
| 94 | Gastrointestinal stromal tumors withBRAFgene fusions. A report of two cases showing low or absentKITexpression resulting in diagnostic pitfalls | 1.7 | 25 | Citations (PDF) |
| 95 | A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS‐NFATC1/2 fusions | 1.7 | 24 | Citations (PDF) |
| 96 | The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast | 2.6 | 27 | Citations (PDF) |
| 97 | Sarcoma classification by DNA methylation profiling | 10.8 | 502 | Citations (PDF) |
| 98 | Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases | 1.7 | 9 | Citations (PDF) |
| 99 | Whole Exome Sequencing Identifies Somatic Variants in an Oral Composite Hemangioendothelioma Characterized by YAP1-MAML2 Fusion | 1.0 | 10 | Citations (PDF) |
| 100 | A molecular study of synovial chondromatosis | 1.7 | 54 | Citations (PDF) |
| 101 | Genetic diversity in alveolar soft part sarcoma: A subset contain variant fusion genes, highlighting broader molecular kinship with other MiT family tumors | 1.7 | 34 | Citations (PDF) |
| 102 | Pan‐Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6–NTRK3 fusion | 2.6 | 65 | Citations (PDF) |
| 103 | Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature | 1.7 | 36 | Citations (PDF) |
| 104 | Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma | 2.3 | 86 | Citations (PDF) |
| 105 | Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior | 2.3 | 26 | Citations (PDF) |
| 106 | Pulmonary Myoepithelial Tumors With Exuberant Reactive Pneumocytes | 2.3 | 13 | Citations (PDF) |
| 107 | Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) | 2.3 | 101 | Citations (PDF) |
| 108 | Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior | 1.7 | 32 | Citations (PDF) |
| 109 | Expanding the differential of superficial tumors with round‐cell morphology: Report of three cases of CIC‐rearranged sarcoma, a potentially under‐recognized entity | 0.7 | 16 | Citations (PDF) |
| 110 | Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas | 1.7 | 27 | Citations (PDF) |
| 111 | A Molecular Reappraisal of Glomus Tumors and Related Pericytic Neoplasms With Emphasis on NOTCH-gene Fusions | 2.3 | 52 | Citations (PDF) |
| 112 | The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor | 5.2 | 13 | Citations (PDF) |
| 113 | Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC) | 2.3 | 64 | Citations (PDF) |
| 114 | Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor | 1.2 | 16 | Citations (PDF) |
| 115 | EWSR1/FUS–CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities | 3.8 | 99 | Citations (PDF) |
| 116 | HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome | 4.5 | 21 | Citations (PDF) |
| 117 | The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome | 1.7 | 65 | Citations (PDF) |
| 118 | High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities | 3.8 | 49 | Citations (PDF) |
| 119 | Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions: a clinicopathologic and molecular study | 3.8 | 62 | Citations (PDF) |
| 120 | BCOR Expression in Mullerian Adenosarcoma | 2.3 | 27 | Citations (PDF) |
| 121 | Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis‐like neural tumor pattern | 1.7 | 92 | Citations (PDF) |
| 122 | Undifferentiated round cell sarcomas with novel SS18‐POU5F1 fusions | 1.7 | 22 | Citations (PDF) |
| 123 | Emerging soft tissue tumors with kinase fusions: An overview of the recent literature with an emphasis on diagnostic criteria | 1.7 | 116 | Citations (PDF) |
| 124 | Variant WWTR1 gene fusions in epithelioid hemangioendothelioma—A genetic subset associated with cardiac involvement | 1.7 | 53 | Citations (PDF) |
| 125 | A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements | 1.7 | 78 | Citations (PDF) |
| 126 | NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations | 3.8 | 81 | Citations (PDF) |
| 127 | Cutaneous intravascular epithelioid hemangioma. A clinicopathological and molecular study of 21 cases | 3.8 | 13 | Citations (PDF) |
| 128 | Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab | 10.9 | 200 | Citations (PDF) |
| 129 | Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma | 3.8 | 45 | Citations (PDF) |
| 130 | Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma | 3.8 | 40 | Citations (PDF) |
| 131 | Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations | 2.3 | 83 | Citations (PDF) |
| 132 | NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma | 2.3 | 81 | Citations (PDF) |
| 133 | Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma | 2.3 | 72 | Citations (PDF) |
| 134 | Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements | 1.5 | 80 | Citations (PDF) |
| 135 | GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions | 3.8 | 107 | Citations (PDF) |
| 136 | The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements | 1.7 | 114 | Citations (PDF) |
| 137 | EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review | 1.7 | 87 | Citations (PDF) |
| 138 | PRRX‐NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm | 1.7 | 33 | Citations (PDF) |
| 139 | JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management | 3.8 | 67 | Citations (PDF) |
| 140 | DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1–NFATc2 fusion from Ewing sarcoma | 1.8 | 69 | Citations (PDF) |
| 141 | Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors | 2.3 | 98 | Citations (PDF) |
| 142 | Novel recurrent PHF1‐TFE3 fusions in ossifying fibromyxoid tumors | 1.7 | 67 | Citations (PDF) |
| 143 | The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement | 1.7 | 45 | Citations (PDF) |
| 144 | Uterine Tumor Resembling Ovarian Sex Cord Tumor | 2.3 | 99 | Citations (PDF) |
| 145 | Adamantinoma-like Ewing Sarcoma of the Salivary Glands | 2.3 | 70 | Citations (PDF) |
| 146 | Pericytoma With t(7;12) and ACTB-GLI1 Fusion | 2.3 | 70 | Citations (PDF) |
| 147 | Cutaneous Syncytial Myoepithelioma Is Characterized by Recurrent EWSR1-PBX3 Fusions | 2.3 | 53 | Citations (PDF) |
| 148 | Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions | 2.3 | 105 | Citations (PDF) |
| 149 | Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum | 2.3 | 90 | Citations (PDF) |
| 150 | Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas | 2.3 | 96 | Citations (PDF) |
| 151 | Expanding the Spectrum of Intraosseous Rhabdomyosarcoma | 2.3 | 130 | Citations (PDF) |
| 152 | BCOR Overexpression in Renal Malignant Solitary Fibrous Tumors | 2.3 | 30 | Citations (PDF) |
| 153 | New advances in the molecular classification of pediatric mesenchymal tumors | 1.7 | 30 | Citations (PDF) |
| 154 | Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone | 3.2 | 43 | Citations (PDF) |
| 155 | Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets | 3.8 | 145 | Citations (PDF) |
| 156 | A 43 year-old woman with primary central nervous system angiosarcoma with CIC-LEUTX gene rearrangement (P3.6-017) | 0.7 | 3 | Citations (PDF) |
| 157 | Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors | 3.1 | 66 | Citations (PDF) |
| 158 | NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors | 2.3 | 130 | Citations (PDF) |
| 159 | Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor | 4.5 | 57 | Citations (PDF) |
| 160 | Novel EWSR1-SMAD3 Gene Fusions in a Group of Acral Fibroblastic Spindle Cell Neoplasms | 2.3 | 71 | Citations (PDF) |
| 161 | A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential | 2.3 | 156 | Citations (PDF) |
| 162 | NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma | 2.3 | 235 | Citations (PDF) |
| 163 | Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information | 3.8 | 99 | Citations (PDF) |
| 164 | Lipofibromatosis-like neural tumor: Case report of a unique infantile presentation | 0.8 | 26 | Citations (PDF) |
| 165 | Genetic analyses of undifferentiated small round cell sarcoma identifies a novel sarcoma subtype with a recurrent CRTC1‐SS18 gene fusion | 3.2 | 36 | Citations (PDF) |
| 166 | Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors | 3.4 | 83 | Citations (PDF) |
| 167 | Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas | 2.3 | 109 | Citations (PDF) |
| 168 | FOXF1 Defines the Core-Regulatory Circuitry in Gastrointestinal Stromal Tumor | 6.8 | 62 | Citations (PDF) |
| 169 | Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland | 2.3 | 116 | Citations (PDF) |
| 170 | High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases | 1.7 | 36 | Citations (PDF) |
| 171 | BCOR-CCNB3 Fusion Positive Sarcomas | 2.3 | 275 | Citations (PDF) |
| 172 | PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities | 2.6 | 98 | Citations (PDF) |
| 173 | Expanding the Spectrum of Genetic Alterations in Pseudomyogenic Hemangioendothelioma With Recurrent Novel ACTB-FOSB Gene Fusions | 2.3 | 93 | Citations (PDF) |
| 174 | Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney | 2.3 | 55 | Citations (PDF) |
| 175 | Uterine PEComas | 2.3 | 188 | Citations (PDF) |
| 176 | COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors | 6.6 | 47 | Citations (PDF) |
| 177 | A recurrent novel MGA–NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma | 0.8 | 54 | Citations (PDF) |
| 178 | A novel group of spindle cell tumors defined by S100 and CD34 co‐expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes | 1.7 | 194 | Citations (PDF) |
| 179 | Ectomesenchymal Chondromyxoid Tumor | 2.3 | 77 | Citations (PDF) |
| 180 | PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence | 5.2 | 50 | Citations (PDF) |
| 181 | Recurrent rearrangements of FOS and FOSB define osteoblastoma | 10.8 | 142 | Citations (PDF) |
| 182 | Diffuse Strong BCOR Immunoreactivity Is a Sensitive and Specific Marker for Clear Cell Sarcoma of the Kidney (CCSK) in Pediatric Renal Neoplasia | 2.3 | 38 | Citations (PDF) |
| 183 | Dermatofibrosarcoma protuberans with a novel COL6A3‐PDGFD fusion gene and apparent predilection for breast | 1.7 | 90 | Citations (PDF) |
| 184 | A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor | 1.6 | 39 | Citations (PDF) |
| 185 | Plexiform fibrohistiocytic tumor: imaging features and clinical findings | 1.3 | 14 | Citations (PDF) |
| 186 | MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification | 3.8 | 179 | Citations (PDF) |
| 187 | A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas | 1.4 | 27 | Citations (PDF) |
| 188 | MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation | 10.8 | 63 | Citations (PDF) |
| 189 | ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements | 1.7 | 72 | Citations (PDF) |
| 190 | CIC-DUX4
Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma | 2.6 | 111 | Citations (PDF) |
| 191 | PGBD5 promotes site-specific oncogenic mutations in human tumors | 14.1 | 85 | Citations (PDF) |
| 192 | EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location | 2.3 | 145 | Citations (PDF) |
| 193 | Primary Pulmonary Myxoid Sarcoma: A Newly Described Entity—Report of a Case and Review of the Literature | 0.6 | 21 | Citations (PDF) |
| 194 | BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1‐SSX1 fusion—A pathologic and molecular pitfall | 1.7 | 40 | Citations (PDF) |
| 195 | Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor | 1.2 | 47 | Citations (PDF) |
| 196 | A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions | 2.3 | 105 | Citations (PDF) |
| 197 | Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma | 2.3 | 111 | Citations (PDF) |
| 198 | TFG‐MET
fusion in an infantile spindle cell sarcoma with neural features | 1.7 | 68 | Citations (PDF) |
| 199 | RBM10-TFE3 Renal Cell Carcinoma | 2.3 | 112 | Citations (PDF) |
| 200 | BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology | 3.8 | 138 | Citations (PDF) |
| 201 | ETV1-Positive Cells Give Rise to
BRAFV600E
-Mutant Gastrointestinal Stromal Tumors | 2.6 | 16 | Citations (PDF) |
| 202 | Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview | 1.7 | 413 | Citations (PDF) |
| 203 | SMARCB1 (INI-1)-deficient Sinonasal Carcinoma | 2.3 | 248 | Citations (PDF) |
| 204 | Head and Neck Round Cell Sarcomas: A Comparative Clinicopathologic Analysis of 2 Molecular Subsets: Ewing and CIC-Rearranged Sarcomas | 1.0 | 22 | Citations (PDF) |
| 205 | Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome | 2.3 | 395 | Citations (PDF) |
| 206 | Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab | 4.5 | 123 | Citations (PDF) |
| 207 | Alveolar soft part sarcoma of the bladder with ASPSCR1-TFE3 gene fusion as a secondary malignancy | 0.1 | 5 | Citations (PDF) |
| 208 | Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions | 10.8 | 105 | Citations (PDF) |
| 209 | In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets | 4.5 | 85 | Citations (PDF) |
| 210 | Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome | 1.7 | 77 | Citations (PDF) |
| 211 | Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion | 2.3 | 84 | Citations (PDF) |
| 212 | Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor | 5.2 | 46 | Citations (PDF) |
| 213 | Novel High-grade Endometrial Stromal Sarcoma | 2.3 | 127 | Citations (PDF) |
| 214 | Benign vascular lesions of the breast diagnosed by core needle biopsy do not require excision | 2.6 | 26 | Citations (PDF) |
| 215 | Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors | 2.3 | 53 | Citations (PDF) |
| 216 | Primary cutaneous adenoid cystic carcinoma withMYBaberrations: report of three cases and comprehensive review of the literature | 0.7 | 29 | Citations (PDF) |
| 217 | PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors | 4.5 | 152 | Citations (PDF) |
| 218 | Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP‐BCORL1 and KDM2A‐WWTR1 | 1.7 | 70 | Citations (PDF) |
| 219 | ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity | 3.8 | 171 | Citations (PDF) |
| 220 | A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors | 1.0 | 30 | Citations (PDF) |
| 221 | Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation | 2.3 | 121 | Citations (PDF) |
| 222 | Recurrent MALAT1–GLI1 oncogenic fusion and GLI1 up‐regulation define a subset of plexiform fibromyxoma | 3.2 | 135 | Citations (PDF) |
| 223 | Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma | 3.4 | 321 | Citations (PDF) |
| 224 | Recurrent CIC Gene Abnormalities in Angiosarcomas | 2.3 | 199 | Citations (PDF) |
| 225 | Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas | 2.3 | 169 | Citations (PDF) |
| 226 | TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers | 2.3 | 223 | Citations (PDF) |
| 227 | Targeted exome sequencing profiles genetic alterations in leiomyosarcoma | 1.7 | 45 | Citations (PDF) |
| 228 | Ewing sarcoma with
ERG
gene rearrangements: A molecular study focusing on the prevalence of
FUS‐ERG
and common pitfalls in detecting
EWSR1‐ERG
fusions by
FISH | 1.7 | 132 | Citations (PDF) |
| 229 | Secondary EWSR1 gene abnormalities in SMARCB1‐deficient tumors with 22q11‐12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results | 1.7 | 52 | Citations (PDF) |
| 230 | Somatic
PIK3CA
mutations as a driver of sporadic venous malformations | 8.7 | 214 | Citations (PDF) |
| 231 | Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements | 2.2 | 10 | Citations (PDF) |
| 232 | Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression | 1.7 | 96 | Citations (PDF) |
| 233 | A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1 -mutant sclerosing are associated with unfavorable outcome | 1.4 | 43 | Citations (PDF) |
| 234 | Long-term effect of chemotherapy–intensity-modulated radiation therapy (chemo-IMRT) on dentofacial development in head and neck rhabdomyosarcoma patients | 0.7 | 35 | Citations (PDF) |
| 235 | A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma | 2.3 | 278 | Citations (PDF) |
| 236 | Thoracic Myoepithelial Tumors | 2.3 | 35 | Citations (PDF) |
| 237 | TFEB-amplified Renal Cell Carcinomas | 2.3 | 150 | Citations (PDF) |
| 238 | Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors | 2.3 | 236 | Citations (PDF) |
| 239 | BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities | 2.3 | 203 | Citations (PDF) |
| 240 | Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes | 1.7 | 137 | Citations (PDF) |
| 241 | Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST | 2.3 | 281 | Citations (PDF) |
| 242 | Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia | 1.3 | 26 | Citations (PDF) |
| 243 | Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy | 2.3 | 197 | Citations (PDF) |
| 244 | Frequent HRAS Mutations in Malignant Ectomesenchymoma | 2.3 | 37 | Citations (PDF) |
| 245 | Primary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites | 0.8 | 21 | Citations (PDF) |
| 246 | Adamantinoma-like Ewing Family Tumors of the Head and Neck | 2.3 | 166 | Citations (PDF) |
| 247 | A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low‐grade fibromyxoid sarcoma: A pathologic and molecular study of 18 cases | 1.7 | 104 | Citations (PDF) |
| 248 | Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications | 2.3 | 251 | Citations (PDF) |
| 249 | EWSR1‐PBX3: A novel gene fusion in myoepithelial tumors | 1.7 | 102 | Citations (PDF) |
| 250 | Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement | 2.3 | 374 | Citations (PDF) |
| 251 | Frequent FOS Gene Rearrangements in Epithelioid Hemangioma | 2.3 | 197 | Citations (PDF) |
| 252 | Thoracic Epithelioid Malignant Vascular Tumors | 2.3 | 140 | Citations (PDF) |
| 253 | Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth | 6.8 | 113 | Citations (PDF) |
| 254 | Primary Renal Sclerosing Epithelioid Fibrosarcoma | 2.3 | 47 | Citations (PDF) |
| 255 | Novel FUS‐KLF17 and EWSR1‐KLF17 fusions in myoepithelial tumors | 1.7 | 94 | Citations (PDF) |
| 256 | Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors | 2.6 | 51 | Citations (PDF) |
| 257 | Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors | 2.8 | 128 | Citations (PDF) |
| 258 | Array CGH analysis identifies two distinct subgroups of primary angiosarcoma of bone | 1.7 | 29 | Citations (PDF) |
| 259 | Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts | 1.7 | 137 | Citations (PDF) |
| 260 | Primary Low-Grade Fibromyxoid Sarcoma of the Kidney in a Child with the Alternative
EWSR1-CREB3L1
Gene Fusion | 0.8 | 27 | Citations (PDF) |
| 261 | ZFP36‐FOSB fusion defines a subset of epithelioid hemangioma with atypical features | 1.7 | 156 | Citations (PDF) |
| 262 | Distinct transcriptional signature and immunoprofile of
CIC‐DUX4
fusion–positive round cell tumors compared to
EWSR1
‐rearranged ewing sarcomas: Further evidence toward distinct pathologic entities | 1.7 | 236 | Citations (PDF) |
| 263 | Round cell sarcomas beyond Ewing: emerging entities | 2.6 | 188 | Citations (PDF) |
| 264 | Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin | 1.7 | 154 | Citations (PDF) |
| 265 | Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: Evidence for a common pathogenesis | 1.7 | 157 | Citations (PDF) |
| 266 | Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor | 4.5 | 49 | Citations (PDF) |
| 267 | Lessons Learned From the Study of 10,000 Patients With Soft Tissue Sarcoma | 3.4 | 434 | Citations (PDF) |
| 268 | SMARCB1 (INI-1)-deficient Carcinomas of the Sinonasal Tract | 2.3 | 199 | Citations (PDF) |
| 269 | EWSR1 and ATF1 rearrangements in clear cell odontogenic carcinoma: presentation of a case | 0.4 | 36 | Citations (PDF) |
| 270 | Malignant vascular tumors—an update | 3.8 | 206 | Citations (PDF) |
| 271 | Novel ZC3H7B‐BCOR, MEAF6‐PHF1, and EPC1‐PHF1 fusions in ossifying fibromyxoid tumors—molecular characterization shows genetic overlap with endometrial stromal sarcoma | 1.7 | 178 | Citations (PDF) |
| 272 | PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors | 14.1 | 593 | Citations (PDF) |
| 273 | Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours | 1.4 | 49 | Citations (PDF) |
| 274 | Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material | 1.7 | 144 | Citations (PDF) |
| 275 | NSD3–NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism | 6.8 | 236 | Citations (PDF) |
| 276 | Dystrophin is a tumor suppressor in human cancers with myogenic programs | 14.1 | 160 | Citations (PDF) |
| 277 | USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location | 1.7 | 105 | Citations (PDF) |
| 278 | Extraskeletal myxoid chondrosarcoma with non–EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology | 1.7 | 97 | Citations (PDF) |
| 279 | Adamantinoma-Like Ewing Sarcoma Mimicking Basal Cell Adenocarcinoma of the Parotid Gland: A Case Report and Review of the Literature | 1.0 | 34 | Citations (PDF) |
| 280 | Toward Better Soft Tissue Sarcoma Staging: Building on American Joint Committee on Cancer Staging Systems Versions 6 and 7 | 1.7 | 59 | Citations (PDF) |
| 281 | Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing | 14.1 | 793 | Citations (PDF) |
| 282 | Angiosarcomas and Other Sarcomas of Endothelial Origin | 1.5 | 37 | Citations (PDF) |
| 283 | Novel MIR143‐NOTCH fusions in benign and malignant glomus tumors | 1.7 | 181 | Citations (PDF) |
| 284 | Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations | 1.6 | 10 | Citations (PDF) |
| 285 | Myxoinflammatory Fibroblastic Sarcoma in Children and Adolescents: Clinicopathologic Aspects of a Rare Neoplasm | 0.8 | 24 | Citations (PDF) |
| 286 | Primary Clear Cell Sarcoma of the Tongue | 1.7 | 18 | Citations (PDF) |
| 287 | Hemosiderotic Fibrolipomatous Tumor, Not an Entirely Benign Entity | 2.3 | 29 | Citations (PDF) |
| 288 | High-Grade KIT-Negative Sarcoma of the Small Bowel in a Patient With Chronic Myeloid Leukemia Receiving Long-Term Tyrosine Kinase Inhibitors | 12.4 | 4 | Citations (PDF) |
| 289 | Novel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma | 1.7 | 581 | Citations (PDF) |
| 290 | Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma | 1.7 | 231 | Citations (PDF) |
| 291 | Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation | 1.7 | 146 | Citations (PDF) |
| 292 | KIT oncogene inhibition drives intratumoral macrophage M2 polarization | 5.9 | 128 | Citations (PDF) |
| 293 | Dedifferentiation in Gastrointestinal Stromal Tumor to an Anaplastic KIT-negative Phenotype | 2.3 | 103 | Citations (PDF) |
| 294 | Cutaneous Syncytial Myoepithelioma | 2.3 | 127 | Citations (PDF) |
| 295 | Primary Myoepithelioma of Bone | 2.3 | 67 | Citations (PDF) |
| 296 | Clear Cell Odontogenic Carcinomas Show EWSR1 Rearrangements | 2.3 | 187 | Citations (PDF) |
| 297 | Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants | 1.5 | 21 | Citations (PDF) |
| 298 | Imatinib resistance and microcytic erythrocytosis in a Kit
V558Δ;T669I/+
gatekeeper-mutant mouse model of gastrointestinal stromal tumor | 5.2 | 28 | Citations (PDF) |
| 299 | Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints | 1.8 | 96 | Citations (PDF) |
| 300 | SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors | 2.1 | 62 | Citations (PDF) |
| 301 | Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours | 2.8 | 10 | Citations (PDF) |
| 302 | Epithelioid Hemangioma of Bone and Soft Tissue: A Reappraisal of a Controversial Entity | 1.4 | 99 | Citations (PDF) |
| 303 | Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data | 1.7 | 330 | Citations (PDF) |
| 304 | High prevalence of
CIC
fusion with double‐homeobox (DUX4) transcription factors in
EWSR1
‐negative undifferentiated small blue round cell sarcomas | 1.7 | 347 | Citations (PDF) |
| 305 | The miR‐17‐92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification | 1.7 | 102 | Citations (PDF) |
| 306 | Oncologic Outcomes of Sporadic, Neurofibromatosis-Associated, and Radiation-Induced Malignant Peripheral Nerve Sheath Tumors | 1.7 | 136 | Citations (PDF) |
| 307 | Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido | 22.6 | 522 | Citations (PDF) |
| 308 | Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking
KIT
and
PDGFRA
mutations | 5.2 | 642 | Citations (PDF) |
| 309 | Advances in sarcoma genomics and new therapeutic targets | 34.5 | 410 | Citations (PDF) |
| 310 | The GIST paradigm: lessons for other kinase‐driven cancers | 3.2 | 113 | Citations (PDF) |
| 311 | Consistent
MYC
and
FLT4
gene amplification in radiation‐induced angiosarcoma but not in other radiation‐associated atypical vascular lesions | 1.7 | 338 | Citations (PDF) |
| 312 | EWSR1‐ATF1 fusion is a novel and consistent finding in hyalinizing clear‐cell carcinoma of salivary gland | 1.7 | 394 | Citations (PDF) |
| 313 | A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites | 1.7 | 533 | Citations (PDF) |
| 314 | Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor | 1.7 | 151 | Citations (PDF) |
| 315 | EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene | 1.7 | 497 | Citations (PDF) |
| 316 | IGF2 over‐expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting | 3.2 | 87 | Citations (PDF) |
| 317 | ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours | 30.6 | 308 | Citations (PDF) |
| 318 | Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy | 14.1 | 700 | Citations (PDF) |
| 319 | Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor | 26.5 | 857 | Citations (PDF) |
| 320 | Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring
KIT
AY502-3ins Mutation: An
In vitro
Mutagenesis Screen for Drug Resistance | 4.5 | 94 | Citations (PDF) |
| 321 | Translocation-Related Sarcomas | 2.8 | 70 | Citations (PDF) |
| 322 | Melanoma Hyperpigmentation Is Strongly Associated With KIT Alterations | 0.3 | 13 | Citations (PDF) |
| 323 | Rhabdomyosarcomatous Differentiation in Gastrointestinal Stromal Tumors After Tyrosine Kinase Inhibitor Therapy | 2.3 | 85 | Citations (PDF) |
| 324 | Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors | 1.7 | 364 | Citations (PDF) |
| 325 | Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas | 3.8 | 52 | Citations (PDF) |
| 326 | Targeted therapies in gastrointestinal stromal tumors | 1.8 | 28 | Citations (PDF) |
| 327 | Molecular Profiling in the Diagnosis and Treatment of High Grade Sarcomas | 0.6 | 14 | Citations (PDF) |
| 328 | Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor | 12.4 | 756 | Citations (PDF) |
| 329 | Plexiform Angiomyxoid Tumor of the Stomach | 2.3 | 46 | Citations (PDF) |
| 330 | DNA Copy Number Analysis in Gastrointestinal Stromal Tumors Using Gene Expression Microarrays | 1.3 | 3 | Citations (PDF) |
| 331 | Chordoma and chondrosarcoma gene profile: implications for immunotherapy | 3.1 | 94 | Citations (PDF) |
| 332 | TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies | 2.3 | 346 | Citations (PDF) |
| 333 | Osteosarcoma with delayed metastasis to the stomach | 1.5 | 13 | Citations (PDF) |
| 334 | L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition | 2.8 | 242 | Citations (PDF) |
| 335 | EWSR1‐CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma | 1.7 | 303 | Citations (PDF) |
| 336 | Skeletal Metastases in Myxoid Liposarcoma: An Unusual Pattern of Distant Spread | 1.7 | 130 | Citations (PDF) |
| 337 | Pediatric and Adult Hepatic Embryonal Sarcoma: A Comparative Ultrastructural Study with Morphologic Correlations | 0.6 | 22 | Citations (PDF) |
| 338 | Comparative Ultrastructural Analysis andKIT/PDGFRAGenotype in 125 Gastrointestinal Stromal Tumors | 0.6 | 22 | Citations (PDF) |
| 339 | Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models | 1.8 | 40 | Citations (PDF) |
| 340 | Subtype Specific Prognostic Nomogram for Patients With Primary Liposarcoma of the Retroperitoneum, Extremity, or Trunk | 3.4 | 375 | Citations (PDF) |
| 341 | Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations | 3.8 | 47 | Citations (PDF) |
| 342 | Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor | 5.2 | 109 | Citations (PDF) |
| 343 | Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors | 1.7 | 110 | Citations (PDF) |
| 344 | A 14-Year Retrospective Review of Angiosarcoma | 1.0 | 400 | Citations (PDF) |
| 345 | Prognostic Factors for Survival in Patients With Locally Recurrent Extremity Soft Tissue Sarcomas | 1.7 | 79 | Citations (PDF) |
| 346 | Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation | 3.8 | 79 | Citations (PDF) |
| 347 | Deep-Seated Plexiform Schwannoma | 2.3 | 90 | Citations (PDF) |
| 348 | Malignant Ectomesenchymoma in the Wrist of a Child: Case Report and Review of the Literature | 0.6 | 17 | Citations (PDF) |
| 349 | Hepatic Follicular Dendritic Cell Sarcoma Without Epstein-Barr Virus Expression | 1.7 | 28 | Citations (PDF) |
| 350 | Midline Carcinoma of Children and Young Adults With NUT Rearrangement | 12.4 | 412 | Citations (PDF) |
| 351 | Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin | 5.2 | 25 | Citations (PDF) |
| 352 | Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: Importance of histological subtype with treatment recommendations | 1.7 | 138 | Citations (PDF) |
| 353 | Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems | 1.7 | 212 | Citations (PDF) |
| 354 | Immunohistochemical and Ultrastructural Comparative Study of External Lamina Structure in 31 Cases of Cellular, Classical, and Melanotic Schwannomas | 0.7 | 23 | Citations (PDF) |
| 355 | Lower Extremity Swelling after Treatment for Thigh Synovial Sarcoma | 1.4 | 0 | Citations (PDF) |
| 356 | Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study | 3.8 | 133 | Citations (PDF) |
| 357 | Targeted molecular therapy for cancer: The application of STI571 to gastrointestinal stromal tumor | 1.6 | 4 | Citations (PDF) |
| 358 | Inconspicuous Insertion 22;12 in Myxoid/Round Cell Liposarcoma Accompanied by the Secondary Structural Abnormality der(16)t(1;16) | 1.9 | 12 | Citations (PDF) |
| 359 | Nemaline myopathy: a possible late complication of Hodgkin’s disease therapy | 1.7 | 53 | Citations (PDF) |
| 360 | Molecular Variability of TLS - CHOP Structure Shows No Significant Impact on the Level of Adipogenesis: A Comparative Ultrastructural and RT-PCR Analysis of 14 Cases of Myxoid/Round Cell Liposarcomas | 0.6 | 18 | Citations (PDF) |
| 361 | Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase | 5.2 | 229 | Citations (PDF) |
| 362 | Metastatic Epithelioid Gastrointestinal Stromal Tumor: Yet Another Tumor with Anemone Cell Features | 0.6 | 5 | Citations (PDF) |
| 363 | Congenital and Childhood Plexiform (Multinodular) Cellular Schwannoma | 2.3 | 77 | Citations (PDF) |
| 364 | Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma | 3.4 | 602 | Citations (PDF) |
| 365 | Targeted molecular therapy for cancer: The application of STI571 to gastrointestinal stromal tumor | 1.6 | 24 | Citations (PDF) |
| 366 | Sinonasal Smooth Muscle Cell Tumors | 1.7 | 42 | Citations (PDF) |
| 367 | PRCC-TFE3 Renal Carcinomas | 2.3 | 339 | Citations (PDF) |
| 368 | Sclerosing Epithelioid Fibrosarcoma 2002, 7, 159-162 | | 2 | Citations (PDF) |
| 369 | The Precrystalline Cytoplasmic Granules of Alveolar Soft Part Sarcoma Contain Monocarboxylate Transporter 1 and CD147 | 2.8 | 118 | Citations (PDF) |
| 370 | Expression Profiling of Synovial Sarcoma by cDNA Microarrays | 2.8 | 183 | Citations (PDF) |
| 371 | Epithelioid Variant of Pleomorphic Liposarcoma: A Comparative Immunohistochemical and Ultrastructural Analysis of Six Cases with Emphasis on Overlapping Features with Epithelial Malignancies | 0.6 | 39 | Citations (PDF) |
| 372 | MAGE antigen expression in monophasic and biphasic synovial sarcoma | 1.7 | 22 | Citations (PDF) |
| 373 | Molecular Diagnosis of Clear Cell Sarcoma | 1.9 | 197 | Citations (PDF) |
| 374 | Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans | 2.8 | 267 | Citations (PDF) |
| 375 | Clinicopathologic correlates of solitary fibrous tumors | 2.7 | 696 | Citations (PDF) |
| 376 | Extra Copies of Chromosomes 7, 8, 12, 19, and 21 are Recurrent in Adamantinoma | 1.9 | 44 | Citations (PDF) |
| 377 | Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma | 2.8 | 657 | Citations (PDF) |
| 378 | Sclerosing Epithelioid Fibrosarcoma | 2.3 | 209 | Citations (PDF) |
| 379 | Clinicopathologic analysis of patients with adult rhabdomyosarcoma | 2.7 | 205 | Citations (PDF) |
| 380 | Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen ny-eso-1 but not mage-a1 or ct7 | 2.8 | 193 | Citations (PDF) |
| 381 | Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks | 22.6 | 2,457 | Citations (PDF) |
| 382 | The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 | 5.2 | 623 | Citations (PDF) |
| 383 | Soft Tissue Tumors of the Abdominal Wall | 2.4 | 116 | Citations (PDF) |
| 384 | Fibrosarcoma Mimicking Plasmacytoma or Carcinoma: An Ultrastructural Study of 4 Cases | 0.6 | 14 | Citations (PDF) |
| 385 | Cytokeratin Immunoreactivity in Ewing's Sarcoma | 2.3 | 183 | Citations (PDF) |
| 386 | Dermatofibrosarcoma protuberans | 2.7 | 462 | Citations (PDF) |
| 387 | Prognostic impact of P53 status in Ewing sarcoma | 2.7 | 140 | Citations (PDF) |
| 388 | Prognostic impact of INK4A deletion in Ewing sarcoma | 2.7 | 103 | Citations (PDF) |
| 389 | Dermatofibrosarcoma Protuberans of the Head and Neck | 1.7 | 120 | Citations (PDF) |
| 390 | Primary Fibrosarcoma and Malignant Fibrous Histiocytoma of Bone - A Comparative Ultrastructural Study: Evidence of a Spectrum of Fibroblastic Differentiation | 0.6 | 38 | Citations (PDF) |
| 391 | Association of EWS-FLI1 Type 1 Fusion with Lower Proliferative Rate in Ewing's Sarcoma | 2.8 | 108 | Citations (PDF) |
| 392 | Alterations of Cell Cycle Regulators in Localized Synovial Sarcoma | 2.8 | 86 | Citations (PDF) |
| 393 | Metastatic thymic carcinoma in a digit: A case report | 1.3 | 19 | Citations (PDF) |
| 394 | Specificity of TLS-CHOP Rearrangement for Classic Myxoid/Round Cell Liposarcoma | 1.9 | 115 | Citations (PDF) |
| 395 | Strong Association of SYT-SSX Fusion Type and Morphologic Epithelial Differentiation in Synovial Sarcoma | 1.4 | 164 | Citations (PDF) |
| 396 | Multifocal Angiosarcoma of the Scalp: A Case Report and Review of the Literature | 0.6 | 20 | Citations (PDF) |
| 397 | Low-Grade Fibrosarcoma With Palisaded Granulomalike Bodies (Giant Rosettes) | 2.3 | 58 | Citations (PDF) |
| 398 | Skeletal and extraskeletal myxoid chondrosarcoma | 2.7 | 203 | Citations (PDF) |
| 399 | SYT–SSX Gene Fusion as a Determinant of Morphology and Prognosis in Synovial Sarcoma | 26.5 | 657 | Citations (PDF) |
| 400 | Molecular Variants of the EWS-WT1 Gene Fusion in Desmoplastic Small Round Cell Tumor | 1.4 | 84 | Citations (PDF) |
| 401 | Primary Leiomyosarcoma of Bone: A Clinicopathologic, Immunohistochemical, and Ultrastructural Study of 33 Patients and a Literature Review | 2.3 | 139 | Citations (PDF) |
| 402 | Case Report: Gastric submucosal neoplasm with CTNNB1 mutation showing GLI1 overexpression and epithelial differentiation | 1.6 | 0 | Citations (PDF) |
| 403 | Alveolar Soft Part Sarcoma: An Updated Review | 1.4 | 0 | Citations (PDF) |
| 404 | NFATC2::NUTM2A/B Fusions Characterize a Novel Indolent Myoepithelial‐Like Neoplasm of the Lungs and Salivary Glands | 1.7 | 5 | Citations (PDF) |
| 405 | Deep-Learning Tool ScVital Enables Species-Agnostic Integration of Cancer Cell States | 2.6 | 1 | Citations (PDF) |
| 406 | Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma | 2.1 | 1 | Citations (PDF) |
| 407 | FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from
PLAG1
-Rearranged Adnexal and Salivary Gland Myoepithelial Tumors | 4.5 | 5 | Citations (PDF) |
| 408 | Expanding the Morphologic and Molecular Spectrum of Spindle Cell Tumors Associated With
TERT
Fusions | 1.7 | 1 | Citations (PDF) |
| 409 | Biallelic
NF1
Inactivation and Widespread Loss of Heterozygosity in a Subset of Unclassified Fibromyxoid Mesenchymal Neoplasms | 1.7 | 1 | Citations (PDF) |
| 410 | Novel genomic risk stratification model for primary high‐grade malignant peripheral nerve sheath tumor (
MPNST
) | 3.2 | 0 | Citations (PDF) |
| 411 | 86 Not all NTRK Fusions in Mesenchymal Neoplasia are Driver Events: Implications on Classification and Targeted Therapy | 1.8 | 0 | Citations (PDF) |
| 412 | 88 ERBB2-mutations as an Alternative Mechanism of Neurofibroma Pathogenesis | 1.8 | 0 | Citations (PDF) |
| 413 | 72 Recurrent NF1 Mutations and Widespread Loss of Heterozygosity in a Subset of Unusual Fibromyxoid Mesenchymal Tumors | 1.8 | 0 | Citations (PDF) |
| 414 | 20 BCORL1::CREBBP Fusions Characterize an Aggressive Frequently Ossifying Bone and Soft Tissue Sarcoma with Predilection for the Clavicular Bone | 1.8 | 0 | Citations (PDF) |
| 415 | 1376 Clinicogenomic Profiling of Hepatic/Splenic Angiosarcoma (AS) Shows Distinct Alterations Compared to Other Anatomical Sites | 1.8 | 0 | Citations (PDF) |
| 416 | Recurrent Epidermal Growth Factor Receptor 2 (ERBB2) Mutations Drive the Pathogenesis of Multifocal Neurofibroma Variants | 3.8 | 0 | Citations (PDF) |
| 417 | Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas? | 1.1 | 0 | Citations (PDF) |
| 418 | A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent
FGFR
fusions | 2.1 | 0 | Citations (PDF) |
| 419 | Comprehensive Clinicopathologic and Molecular Analysis of Mesenchymal Tumors With
BRAF
Fusions | 1.7 | 0 | Citations (PDF) |
| 420 | Not all
NTRK
fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy | 2.1 | 0 | Citations (PDF) |
